Abstract: The persistent threat that lung cancer poses to people's health emphasizes the urgent requirement for cuttingedge detection technology. This work offers a novel approach for diagnosing and ...

ABSTRACT: Lung cancer stands as the preeminent cause of cancer-related mortality globally. Prompt and precise diagnosis, coupled with effective treatment, is imperative to reduce the fatality rates ...

ABSTRACT: Lung cancer stands as the preeminent cause of cancer-related mortality globally. Prompt and precise diagnosis, coupled with effective treatment, is imperative to reduce the fatality rates ...

A promising new study has identified a highly accurate, non-invasive method to diagnose non-small cell lung cancer (NSCLC) using a blood test based on tRNA signatures. NSCLC accounts for roughly 85% ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Surabhi Srivastava, Commercial Head UK and EU at Qure.ai, discusses how integrating artificial intelligence can reduce chest X-ray reporting times and accelerate early lung cancer diagnosis Healthcare ...

The gut microbiome has emerged as a key modulator of immune responses and treatment efficacy in oncology. Growing evidence links gut dysbiosis to resistance against immune checkpoint inhibitors (ICIs) ...

Ifinatamab deruxtecan targets B7-H3 and is a potential first-in-class antibody-drug conjugate for extensive-stage small cell lung cancer. The FDA's Breakthrough Therapy Designation aims to expedite ...

Two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of Engineering researchers report on a powerful new method that significantly improves the ...